Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Brain Disease Modalities & Software Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of brain disorders and increasing awareness regarding seeking diagnosis
5.1.1.2. Government initiatives encouraging the use of digital solutions in brain disease management
5.1.1.3. Increasing adoption of neuroimaging modalities for brain disease testing
5.1.2. Restraints
5.1.2.1. Complexities of integrating software technologies in testing equipment
5.1.3. Opportunities
5.1.3.1. Introduction of advanced brain disease software based on AI and ML
5.1.3.2. Investments in the expansion and establishment of brain disease treatment centers
5.1.4. Challenges
5.1.4.1. Concerns associated with data privacy and security breaches
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Brain Disease Modalities & Software Market, by Product
6.1. Introduction
6.2. Brain Analysis Software
6.3. Brain Imaging Modalities
6.4.1. CT Devices
6.4.2. MRI Devices
6.4.3. PET Devices
6.4.4. PET-CT
6.4.5. PET-MRI

7. Brain Disease Modalities & Software Market, by Patient Type
7.1. Introduction
7.2. Adults
7.3. Infants
7.4. Pediatrics

8. Brain Disease Modalities & Software Market, by Indication
8.1. Introduction
8.2. Brain Diseases
8.3.1. Brain Cancer
8.3.2. Central Nervous System Cancer
8.3.3. Idiopathic Epilepsy
8.3.4. Ischemic Stroke
8.3. Neurodegenerative Diseases
8.4.1. Alzheimer’s Disease
8.4.2. Motor Neuron Disease
8.4.3. Multiple Sclerosis
8.4.4. Parkinson’s Disease

9. Americas Brain Disease Modalities & Software Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Brain Disease Modalities & Software Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Brain Disease Modalities & Software Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Aspect Imaging Ltd.
13.1.2. Brainomix Limited
13.1.3. Canon Medical Systems Corporation
13.1.4. Carestream Health, Inc.
13.1.5. Esaote S.p.A.
13.1.6. Fujifilm Holdings Corporation
13.1.7. General Electric Company,
13.1.8. Imaging Biometrics LLC
13.1.9. International Business Machines Corporation
13.1.10. IXICO plc.
13.1.11. Koninklijke Philips N.V.,
13.1.12. MIM Software, Inc.
13.1.13. Quantib B.V.
13.1.14. ScienceSoft USA Corporation
13.1.15. Siemens Healthineers AG
13.1.16. VUNO Inc.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. BRAIN DISEASE MODALITIES & SOFTWARE MARKET RESEARCH PROCESS
FIGURE 2. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2023 VS 2030
FIGURE 3. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BRAIN DISEASE MODALITIES & SOFTWARE MARKET DYNAMICS
FIGURE 7. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
FIGURE 10. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BRAIN DISEASE MODALITIES & SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 9. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CT DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MRI DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PET DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PET-CT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PET-MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 15. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 19. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 21. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IDIOPATHIC EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 27. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ALZHEIMER’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MOTOR NEURON DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 50. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 52. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 55. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 56. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 58. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 61. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 82. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 84. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 85. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 87. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 88. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 90. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 91. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 92. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 93. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 100. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 102. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 103. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 105. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 136. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 138. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 139. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 141. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 155. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 157. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 158. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 160. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 161. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 163. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 164. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 165. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 166. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 167. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 169. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 170. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 172. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 173. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 175. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 177. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 178. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 179. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 181. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 182. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 183. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 184. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 191. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 193. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 194. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 196. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 209. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 211. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 212. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 213. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 214. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 215. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 217. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 218. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 220. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 221. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 223. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 224. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 225. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 226. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 245. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 246. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 247. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 248. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 249. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 250. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 263. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. TU